ArticleAnnals of hematology2025

A 30-minute intravenous infusion of rituximab is safe and cost-effective (SpeedR).

Björn Engelbrekt Wahlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.